Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Status unconfirmed · Phase 2

Conditions studied: Lung Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus filgrastim in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Key facts

Study ID

NCT00006215

Run by

Amgen

Starts

1999-10-01

Last updated by the study team

2013-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Gould Medical Group — Modesto, California, United States
• Sibley Memorial Hospital — Washington D.C., District of Columbia, United States
• Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
• Georgia Cancer Treatment Center, P.C. — Riverdale, Georgia, United States
• Oncology and Hematology Associates — Westwood, Kansas, United States
• Veterans Affairs Medical Center - Brooklyn — Brooklyn, New York, United States
• Hematology-Oncology Associates of Rockland, P.C. — New City, New York, United States
• New York Medical College — Valhalla, New York, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Community Oncology Group — Independence, Ohio, United States
• CCOP - Dayton — Kettering, Ohio, United States
• CCOP - Toledo Community Hospital Oncology Program — Toledo, Ohio, United States
• Charleston Hematology-Oncology, P.A. — Charleston, South Carolina, United States
• Trident Palmetto Hematology/Oncology — North Charleston, South Carolina, United States
• Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group — Memphis, Tennessee, United States
• Texas Cancer Care — Fort Worth, Texas, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• Hematology & Oncology Associates of Virginia — Richmond, Virginia, United States
• Morgantown Internal Medicine Group — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.